Jason S Starr (Jason Starr)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Locally Advanced

Randomized Controlled Trial

Cross Sectional

Top Venues

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Osama Mosalem, Tucker W Coston, Robin Imperial, Elizabeth Mauer, Christopher Thompson, Binyam Yilma, Tanios S Bekaii-Saab, Melissa Conrad Stoppler, Jason S Starr
A comprehensive analysis of POLE/POLD1 genomic alterations in colorectal cancer. The oncologist (2024)
Blake Jeffrey McKinley, Tucker W Coston, Jason S Starr
Primary Resistance to RET Inhibition in a RET Fusion-Positive Pancreatic Neuroendocrine Carcinoma. The oncologist (2024)
Blake Jeffrey McKinley, Tucker W Coston, Jason S Starr
Primary Resistance to RET Inhibition in a RET Fusion-Positive Pancreatic Neuroendocrine Carcinoma. The oncologist (2024)
Jason S Starr, Mohamad Bassam B Sonbol, Timothy J Hobday, Akash Sharma, Ayse Tuba Kendi, Thorvardur R Halfdanarson
Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights. OncoTargets and therapy 13 (2020)
Jason S Starr, Brian Ramnaraign
Germline BRCA1 mutated esophageal squamous cell carcinoma. Rare tumors 12 (2020)